These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3978025)

  • 1. Serum concentrations and urinary excretion of pinacidil and its major metabolite, pinacidil pyridine-N-oxide following i.v. and oral administration in healthy volunteers.
    McBurney A; Farrow PR; Ainsworth S; Ward JW
    Br J Clin Pharmacol; 1985 Jan; 19(1):91-4. PubMed ID: 3978025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of formulation on the pharmacokinetics of orally administered pinacidil in humans.
    McBurney A; Farrow PR; Ward JW
    J Pharm Sci; 1987 Dec; 76(12):940-1. PubMed ID: 3440941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of the new antihypertensive agent pinacidil in rat, dog and man.
    Eilertsen E; Magnussen MP; Petersen HJ; Rastrup-Andersen N; Sørensen H; Arrigoni-Martelli E
    Xenobiotica; 1982 Mar; 12(3):187-96. PubMed ID: 7113255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and hypotensive effect in healthy volunteers of pinacidil, a new potent vasodilator.
    Ward JW; McBurney A; Farrow PR; Sharp P
    Eur J Clin Pharmacol; 1984; 26(5):603-8. PubMed ID: 6468476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and bioavailability of pinacidil capsules in human volunteers.
    Laher MS; Hickey MP
    J Int Med Res; 1985; 13(3):159-62. PubMed ID: 4007251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of pinacidil N-oxide during chronic treatment with pinacidil.
    McBurney A; Henry JA; Ward JW
    Eur J Clin Pharmacol; 1988; 35(1):93-5. PubMed ID: 3220100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition of [14C]pinacidil in humans.
    DeLong AF; Oldham SW; DeSante KA; Nell G; Henry DP
    J Pharm Sci; 1988 Feb; 77(2):153-6. PubMed ID: 3361430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid chromatographic determination of pinacidil, a new antihypertensive drug, and its major metabolite, pinacidil N-oxide, in plasma.
    Hamilton M; Farid KZ; Henry DP
    J Chromatogr; 1986 Mar; 375(2):359-67. PubMed ID: 3700560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective disposition and metabolism of pinacidil in rat.
    Sakamoto K; Nakamura Y
    Xenobiotica; 1994 Apr; 24(4):329-38. PubMed ID: 8059536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamics and pharmacokinetics of pinacidil after a single dose of a new slow release tablet in healthy volunteers.
    Bareggi SR; Gambaro V; Valenti M; Benvenuti C
    Arzneimittelforschung; 1998 Jul; 48(7):730-3. PubMed ID: 9706373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and distribution of the new antihypertensive agent pinacidil in rat, dog and man.
    Eilertsen E; Hart JW; Magnussen MP; Sørensen H; Arrigoni-Martelli E
    Xenobiotica; 1982 Mar; 12(3):177-85. PubMed ID: 7113254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary metabolites of pinacidil. II. Species difference in the metabolism of pinacidil.
    Sakamoto K; Nakamura Y
    Xenobiotica; 1993 Jun; 23(6):649-56. PubMed ID: 8212738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of food on the bioavailability of sustained-release pinacidil in humans.
    McBurney A; Farrow PR; Ward JW
    J Pharm Sci; 1988 Jan; 77(1):68-9. PubMed ID: 3346824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of effect of pinacidil on theophylline pharmacokinetics and metabolism in man.
    Nielsen-Kudsk JE; Nielsen CB; Mellemkjaer S; Siggaard C
    Pharmacol Toxicol; 1990 Aug; 67(2):156-8. PubMed ID: 2255669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pinacidil. Preclinical investigations.
    Ahnfelt-Rønne I
    Drugs; 1988; 36 Suppl 7():4-9. PubMed ID: 3076134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamics and pharmacokinetics of pinacidil in normotensive volunteers after repeated doses of a new slow-release tablet formulation.
    Bareggi SR; Gambaro V; Valenti M; Benvenuti C
    Arzneimittelforschung; 1999 Jan; 49(1):21-5. PubMed ID: 10028374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary metabolites of pinacidil: I. Isolation and identification of the metabolites in rat urine.
    Sakamoto K; Nakamura Y
    Xenobiotica; 1993 Apr; 23(4):391-400. PubMed ID: 8337897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potassium channel modulation: effect of pinacidil on insulin release in healthy volunteers.
    Links TP; Smit AJ; Reitsma WD
    J Clin Pharmacol; 1995 Mar; 35(3):291-4. PubMed ID: 7608319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Food Intake on the Relative Bioavailability of Amifampridine Phosphate Salt in Healthy Adults.
    Haroldsen PE; Musson DG; Hanson B; Quartel A; O'Neill CA
    Clin Ther; 2015 Jul; 37(7):1555-63. PubMed ID: 26101174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cirrhosis and debrisoquin phenotype on the disposition and effects of pinacidil.
    Shaheen O; Patel J; Avant GR; Hamilton M; Wood AJ
    Clin Pharmacol Ther; 1986 Dec; 40(6):650-5. PubMed ID: 3780126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.